Skip to main content
OpenTrials

Clinical trial condition

Paramyxoviridae Infections

Explore clinical trials studying Paramyxoviridae Infections. Study availability and eligibility vary by location and protocol.

354 public trials 28 recruiting studies
Refine in advanced search Browse all conditions

Paramyxoviridae Infections trial results

Completed

A Long-term Follow-up Study to Evaluate the Impact of Lumicitabine on the Incidence of Asthma and/or Wheezing in Infants and Children With a History of Respiratory Syncytial Virus Infection

NCT03332459

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • Fukuyama City Hospital Fukuyama, Japan
  • Hirosaki National Hospital Hirosaki, Japan
  • National Hospital Organization Niigata National Hospital Niigata, Japan
  • National Hospital Organization Beppu Medical Center Ōita, Japan
View Trial Details
Completed

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age

NCT02184572

Conditions
Infections, Measles, Measles-Mumps-Rubella Vaccine, +16 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Fayetteville, Arkansas, United States
  • GSK Investigational Site Jonesboro, Arkansas, United States
View all 95 locations
View Trial Details
Completed

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life

NCT01681992

Conditions
Infections, Measles, Measles-Mumps-Rubella Vaccine, +15 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Jonesboro, Arkansas, United States
View all 81 locations
View Trial Details
Completed

Phase I Trial of Measles Vectored Chikungungya Vaccine

NCT03028441

Conditions
Alphavirus Infections, Arbovirus Infections, Chikungunya Fever, +11 more
Locations
  • Emory Children's Center - Pediatric Infectious Diseases Atlanta, Georgia, United States
  • University of Iowa - Vaccine Research and Education Unit Iowa City, Iowa, United States
  • Baylor College of Medicine - Molecular Virology and Microbiology Houston, Texas, United States
View Trial Details

Related conditions